Ronald Antes

Ronald E. Antes II currently serves as the Director of Quality Assurance for Research and Development at the Sabin Vaccine Institute, where responsibilities include developing and managing GXP Quality aspects for projects supporting Phase II trials, and ensuring compliance with regulatory standards. Prior roles include Executive Director of Quality Assurance at SAB Biotherapeutics, overseeing quality management systems for human polyclonal therapeutics, and Director of 503(b) Quality at US Compounding, where oversight included quality management systems for compounded drug manufacture. Ronald's extensive experience extends back to positions at RxBio, Inc., PRACS Institute, Cetero Research, WYETH BIOTECH, and DPT Laboratories, each contributing to expertise in quality assurance, regulatory compliance, and drug development processes. Ronald holds a Bachelor of Science in Chemistry from the University of Oregon.